PTEN and cancer: The results suggested that this PTEN-NP platform elicited a robust and safe antitumor immune response by inducing tumor-cell autophagy and releasing damage-associated molecular patterns (DAMPs), thereby triggering tumor immunogenic cell death (ICD) and sensitizing cancers to immune checkpoint blockade (ICB) therapy.